DAPZURA RT
NDC 60977-145, daptomycin, injection, powder, lyophilized, for solution, from Baxter Healthcare Corporation.
- Product NDC
- 60977-145
- Status
- Listed
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA213645
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60977-145 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPTOMYCIN500 mg/10mL
Pharmacologic classes
Lipopeptide Antibacterial [EPC]; Lipopeptides [CS]
| Package NDC | NDC-11 | Package |
|---|
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/cb1283e1-35b8-425c-b338-d9ac0c7161f8
Use it
Look up 60977-145 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60977-145 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60977-145. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.